News Focus
News Focus
Replies to #16664 on Biotech Values
icon url

DewDiligence

10/12/05 4:40 PM

#16803 RE: bladerunner1717 #16664

Re: MRVT

>>Is this thing worth a shot at $.40/share?<<

Perhaps as a trade, but not as an investment. I fail to see how a knock-off of a drug that is itself becoming obsolete (Visudyne) is a good business prospect.